{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:38:32Z","timestamp":1754109512487},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,10]]},"DOI":"10.7759\/cureus.55884","type":"journal-article","created":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T11:54:25Z","timestamp":1710071665000},"source":"Crossref","is-referenced-by-count":3,"title":["Successful Treatment of Mucus Plug Due to Allergic Bronchopulmonary Aspergillosis Using Dupilumab"],"prefix":"10.7759","author":[{"given":"Toshiyuki","family":"Sumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keito","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Koshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.2.442","article-title":"Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India","volume":"130","author":"Agarwal R","year":"2006","unstructured":"Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest. 2006, 130:442-8. 10.1378\/chest.130.2.442","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/26.4.561","article-title":"Adverse events associated with itraconazole in 189 patients on chronic therapy","volume":"26","author":"Tucker RM","year":"1990","unstructured":"Tucker RM, Haq Y, Denning DW, Stevens DA. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother. 1990, 26:561-6. 10.1093\/jac\/26.4.561","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2022.101723","article-title":"Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: a case report","volume":"39","author":"Kai Y","year":"2022","unstructured":"Kai Y, Yoshikawa M, Matsuda M, et al.. Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: a case report. Respir Med Case Rep. 2022, 39:101723. 10.1016\/j.rmcr.2022.101723","journal-title":"Respir Med Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42464","article-title":"A case of allergic bronchopulmonary aspergillosis with failure of benralizumab and response to dupilumab","volume":"15","author":"Kotetsu Y","year":"2023","unstructured":"Kotetsu Y, Ogata H, Sha K, Moriwaki A, Yoshida M. A case of allergic bronchopulmonary aspergillosis with failure of benralizumab and response to dupilumab. Cureus. 2023, 15:e42464. 10.7759\/cureus.42464","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.6679-20","article-title":"Successful treatment of mepolizumab- and prednisolone-resistant allergic bronchopulmonary aspergillosis with dupilumab","volume":"60","author":"Mikura S","year":"2021","unstructured":"Mikura S, Saraya T, Yoshida Y, et al.. Successful treatment of mepolizumab- and prednisolone-resistant allergic bronchopulmonary aspergillosis with dupilumab. Intern Med. 2021, 60:2839-42. 10.2169\/internalmedicine.6679-20","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2023.101964","article-title":"Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis","volume":"47","author":"Kawasaki Y","year":"2024","unstructured":"Kawasaki Y, Nishiki K, Ishizaki T. Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis. Respir Med Case Rep. 2024, 47:101964. 10.1016\/j.rmcr.2023.101964","journal-title":"Respir Med Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201807-485AW","article-title":"Autopsy and imaging studies of mucus in asthma. Lessons learned about disease mechanisms and the role of mucus in airflow obstruction","volume":"15","author":"Dunican EM","year":"2018","unstructured":"Dunican EM, Watchorn DC, Fahy JV. Autopsy and imaging studies of mucus in asthma. Lessons learned about disease mechanisms and the role of mucus in airflow obstruction. Ann Am Thorac Soc. 2018, 15:S184-91. 10.1513\/AnnalsATS.201807-485AW","journal-title":"Ann Am Thorac Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised clinical practice guidelines for diagnosing, classifying, and treating allergic bronchopulmonary aspergillosis\/mycoses: a Delphi statement from the ISHAM-ABPA working group. [PREPRINT]","author":"Agarwal R","year":"2024","unstructured":"Agarwal R, Singh Sehgal I, Muthu V, et al.. Revised clinical practice guidelines for diagnosing, classifying, and treating allergic bronchopulmonary aspergillosis\/mycoses: a Delphi statement from the ISHAM-ABPA working group. [PREPRINT]. Eur Respir J. 2024, 10.1183\/13993003.00061-2024","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano K","year":"2021","unstructured":"Asano K, Hebisawa A, Ishiguro T, et al.. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation. J Allergy Clin Immunol. 2021, 147:1261-8.e5. 10.1016\/j.jaci.2020.08.029","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/8255.4423","article-title":"Allergic bronchopulmonary aspergillosis (ABPA)-the high resolution computed tomography (HRCT) chest imaging scenario","volume":"8","author":"Kaur M","year":"2014","unstructured":"Kaur M, Sudan DS. Allergic bronchopulmonary aspergillosis (ABPA)-the high resolution computed tomography (HRCT) chest imaging scenario. J Clin Diagn Res. 2014, 8:RC05-7. 10.7860\/JCDR\/2014\/8255.4423","journal-title":"J Clin Diagn Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1102LE","article-title":"Effects of dupilumab on mucus plugging and ventilation defects in patients with moderate-to-severe asthma: a randomized, double-blind, placebo-controlled trial","volume":"208","author":"Svenningsen S","year":"2023","unstructured":"Svenningsen S, Kjarsgaard M, Haider E, et al.. Effects of dupilumab on mucus plugging and ventilation defects in patients with moderate-to-severe asthma: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2023, 208:995-7. 10.1164\/rccm.202306-1102LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12081","article-title":"Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab","volume":"11","author":"van der Veer T","year":"2021","unstructured":"van der Veer T, Dallinga MA, van der Valk JP, Kappen JH, In 't Veen JC, van der Eerden MM, Braunstahl GJ. Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab. Clin Transl Allergy. 2021, 11:e12081. 10.1002\/clt2.12081","journal-title":"Clin Transl Allergy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i23.6922","article-title":"Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: a case report","volume":"9","author":"Nishimura T","year":"2021","unstructured":"Nishimura T, Okano T, Naito M, et al.. Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: a case report. World J Clin Cases. 2021, 9:6922-8. 10.12998\/wjcc.v9.i23.6922","journal-title":"World J Clin Cases"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1147","article-title":"Tezepelumab treatment for allergic bronchopulmonary aspergillosis","volume":"11","author":"Ogata H","year":"2023","unstructured":"Ogata H, Sha K, Kotetsu Y, et al.. Tezepelumab treatment for allergic bronchopulmonary aspergillosis. Respirol Case Rep. 2023, 11:e01147. 10.1002\/rcr2.1147","journal-title":"Respirol Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228247-successful-treatment-of-mucus-plug-due-to-allergic-bronchopulmonary-aspergillosis-using-dupilumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T11:54:29Z","timestamp":1710071669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228247-successful-treatment-of-mucus-plug-due-to-allergic-bronchopulmonary-aspergillosis-using-dupilumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,10]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.55884","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,10]]}}}